New York University School of Medicine
New York, 10016, United States
NCT Number: NCT03601741
This is a prospective pilot study using a randomized, controlled, single blinded, crossover trial design, evaluating the effect of daily antimicrobial stethoscope diaphragm covers versus uncovered stethoscope. Stethoscopes will be cleaned Sani-cloth germicidal disposable wipes which are effective against MRSA. Each participant will then be randomly assigned to 7 days in either the intervention or the control arm. At the end of the 7 days participants stethoscopes will be cleaned again. This will be followed by another 7 days in the arm that they are not in during the first 7 days.
The primary endpoint is MRSA colony count from stethoscope diaphragms cultures at 7 days, focusing on the difference between the intervention and the control periods. The secondary endpoint is the rate of hospital acquired MRSA infection in patients treated by residents during each period.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
New York, 10016, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will receive package with instructions to use stethoscope cover, and are then instructed to switch in 7 days
Patients receive instruction to begin with no covers, and are then instructed to switch in 7 days
Time frame: 7 Days
Total CFU of each selected pathogen at 7 days compared by paired Mann-Whitney U tests, with each patient serving as their own control
Time frame: 14 Days
Rates on nosocomial infection in each arm compared through use of Kaplan Meier curves
NYU Langone Health
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04104178
MRSA, MRSA Colonization
Hvidovre, Denmark
View Trial DetailsNCT03181932
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Mobile, Alabama, United States
View Trial DetailsNCT02690415
MRSA
Springfield, Illinois, United States
View Trial DetailsNCT03304873
MRSA
New York, United States
View Trial Details